PLoS ONE · 2014 · 71 citations · 47 references
Life SciencesBiochemistryMolecular BiologyEnzymologyProtein BiochemistryProtein EngineeringEnzyme FunctionEnzyme StabilityEnzyme-substrate RecognitionProtein DesignProtein PhosphorylationProtein StructureCatalytic StabilityPhosphatase Enzyme ActivityPhosphatase Substrate SpecificityPhosphatasesSelectivitySkeletal MineralizationSubstrate Binding SpecificityTurnover Number
Recombinant alkaline phosphatases are becoming promising protein therapeutics to prevent skeletal mineralization defects, inflammatory bowel diseases, and treat acute kidney injury. By substituting the flexible crown domain of human intestinal alkaline phosphatase (IAP) with that of the human placental isozyme (PLAP) we generated a chimeric enzyme (ChimAP) that retains the structural folding of IAP, but displays greatly increased stability, active site Zn²⁺ binding, increased transphosphorylation, a higher turnover number and narrower substrate specificity, with comparable selectivity for bacterial lipopolysaccharide (LPS), than the parent IAP isozyme. ChimAP shows promise as a protein therapeutic for indications such as inflammatory bowel diseases, gut dysbioses and acute kidney injury.
47
The SWISS-MODEL Repository and associated resources
Florian Kiefer, Konstantin Arnold, Michael Künzli et al. · Nucleic Acids Research · 2008 · 2K citations · Full text
Lovisa Hessle, H. Clarke Anderson, Sonoko Narisawa et al. · Proceedings of the National Academy of Sciences · 2002 · 859 citations · Full text